| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $57.0M | +32.1% |
| SG&A Expense | $15.8M | -15.5% |
| Operating Income | -$77.0M | -24.5% |
| Interest Expense | $3.0M | +3.6% |
| Net Income | -$81.2M | -25.6% |
| EPS (Basic) | -$1.49 | +12.4% |
| EPS (Diluted) | -$1.49 | +12.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.1M | -27.3% |
| Current Assets | $18.0M | -68.2% |
| Total Assets | $18.9M | -67.2% |
| Current Liabilities | $14.1M | +39.4% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $14.8M | -58.7% |
| Stockholders' Equity | $4.2M | -81.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.6M | -28.3% |
| Capital Expenditures | $426K | +54.9% |
| Investing Cash Flow | $30.9M | +914.9% |
| Financing Cash Flow | $32.2M | +920.8% |
| Free Cash Flow | -$70.0M | -28.5% |